Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1427-1433

  Schmid, Tobias ^a   Bajer, Magdalena M ^a   Blees, Johanna S ^a   Eifler, Lisa K ^a   Milke, Larissa ^a   Rübsamen, Daniela ^a   Schulz, Kathrin ^a   Weigert, Andreas ^a   Baker, Alyson R ^b   Colburn, Nancy H ^b   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COMPLEMENTARY DNA; CYCLOHEXIMIDE; CYTOKINE; DEXTRAN SULFATE; INTERLEUKIN 6; INTERLEUKIN 8; LACTACYSTIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PDCD4 PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROGRAMMED CELL DEATH 4 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CYTOKINE RELEASE; GENE EXPRESSION; HALF LIFE TIME; INFLAMMATION; MACROPHAGE ACTIVATION; MONOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 80053144773     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr131     Document Type: Article

References (45)

1. Yang,H.S. et al. (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol., 23, 26-37.
2. Chang,J.H. et al. (2009) Crystal structure of the eIF4A-PDCD4 complex. Proc. Natl Acad. Sci. USA, 106, 3148-3153.
3. LaRonde-LeBlanc,N. et al. (2007) Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol. Cell. Biol., 27, 147-156.
4. Loh,P.G. et al. (2009) Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J., 28, 274-285.
5. Svitkin,Y.V. et al. (2001) The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5# secondary structure. RNA, 7, 382-394.
6. Moerke,N.J. et al. (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell, 128, 257-267.
7. Yang,H.S. et al. (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol., 26, 1297-1306.
8. Asangani,I.A. et al. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
9. Leupold,J.H. et al. (2007) Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sptranscription factors. Oncogene, 26, 4550-4562.
10. Santhanam,A.N. et al. (2010) Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene, 29, 3921-3932.
11. Wang,Q. et al. (2008) Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene, 27, 1527-1535.
12. Jansen,A.P. et al. (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res., 65, 6034-6041.
13. Hilliard,A. et al. (2006) Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J. Immunol., 177, 8095-8102.
14. Schmid,T. et al. (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res., 68, 1254-1260.
15. Dorrello,N.V. et al. (2006) S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science, 314, 467-471.
16. Frankel,L.B. et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 283, 1026-1033.
17. Lu,Z. et al. (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene, 27, 4373-4379.
18. Folini,M. et al. (2010) miR-21: an oncomir on strike in prostate cancer. Mol. Cancer, 9, 12.
19. Motoyama,K. et al. (2010) Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int. J. Oncol., 36, 1089-95.
20. Reis,P.P. et al. (2010) Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol. Cancer, 9, 238.
21. Allgayer,H. (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit. Rev. Oncol. Hematol., 73, 185-91.
22. Bredel,M. et al. (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA, 302, 261-275.
23. Carinci,F. et al. (2005) Potential markers of tongue tumor progression selected by cDNA microarray. Int. J. Immunopathol. Pharmacol., 18, 513-524.
24. Fang,W. et al. (2008) Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J. Transl. Med., 6, 32.
25. Fassan,M. et al. (2010) Programmed cell death 4 protein in esophageal cancer. Oncol. Rep., 24, 135-9.
26. Gao,F. et al. (2007) Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol. Rep., 17, 123-128.
27. Hayashi,A. et al. (2010) Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation. Hum. Pathol., 41, 1507-1515.
28. Matsuhashi,S. et al. (2007) Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp. Dermatol., 16, 179-184.
29. Wen,Y.H. et al. (2007) Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol. Rep., 18, 1387-1393.
30. Zhang,Z. et al. (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene, 20, 4450-4456.
31. Mudduluru,G. et al. (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer, 110, 1697-1707.
32. Akar,U. et al. (2010) Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol. Cancer Ther., 9, 1180-1187.
33. Blees,J.S. et al. (2010) Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4. J. Biomol. Screen., 15, 21-29.
34. Jansen,A.P. et al. (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol. Cancer Ther., 3, 103-110.
35. Colotta,F. et al. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30, 1073-1081.
36. Hanahan,D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
37. Balkwill,F. et al. (2004) Cancer: an inflammatory link. Nature, 431, 405-406.
38. Mantovani,A. et al. (2008) Cancer-related inflammation. Nature, 454, 436-444.
39. Pages,F. et al. (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene, 29, 1093-1102.
40. Sica,A. et al. (2008) Cancer related inflammation: the macrophage connection. Cancer Lett., 267, 204-215.
41. Solinas,G. et al. (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol., 86, 1065-1073.
42. Porta,C. et al. (2009) Cellular and molecular pathways linking inflammation and cancer. Immunobiology, 214, 761-777.
43. Mantovani,A. et al. (2007) Inflammation and cancer: breast cancer as a prototype. Breast, 16 (suppl. 2), S27-S33.
44. Yasuda,M. et al. (2010) Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment. Mol. Carcinog., 49, 837-848.
45. Sheedy,F.J. et al. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol., 11, 141-147.